Anlon Healthcare Limited (AHCL)
Disclosure of material issue
Disclosure on approved share swap for acquisition of 44.94% in Apiqo Organics and 47.41% in Bizotic Lifescience.
- AGM held on Sep 5, 2026, approved share swap proposal.
- Floor price fixed at Rs.17.85 per share as per SEBI ICDR Regulations.
- Valuation report dated Sep 1, 2026, confirms fair value at Rs.17.85 per share.
- List of ultimate beneficial owners of proposed allottees disclosed.
- Certificate from Practicing Company Secretary confirms compliance with SEBI ICDR rules.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 AHCL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add AHCL to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Anlon Healthcare Limited
Important.
The summary above is generated automatically from Anlon Healthcare Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.